AKT1 and acute myeloid leukemia: However, based on our functional phosphosite scoring analysis, we could pinpoint AKT as a kinase with key activity in selinexor-resistant AML cells, immediately generating the testable hypothesis that AKT inhibition with selinexor would, at least partially, overcome this resistance.